药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dioxaphetyl butyrate
Chromium gluconate
Ertugliflozin may increase the excretion rate of Chromium gluconate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Chromic nitrate
Ertugliflozin may increase the excretion rate of Chromic nitrate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Chromic citrate
Ertugliflozin may increase the excretion rate of Chromic citrate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Lithium carbonate
Ertugliflozin may increase the excretion rate of Lithium carbonate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Lithium citrate
Ertugliflozin may increase the excretion rate of Lithium citrate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Lithium hydroxide
Ertugliflozin may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Pentetic acid
Ertugliflozin may increase the excretion rate of Pentetic acid which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Patent Blue
Ertugliflozin may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Bismuth subgallate
Ertugliflozin may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Albutrepenonacog alfa
Ertugliflozin may increase the excretion rate of Albutrepenonacog alfa which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Fenofibric acid
Ertugliflozin may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Almasilate
Ertugliflozin may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Ipecac
Ertugliflozin may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Dichlorobenzyl alcohol
Ertugliflozin may increase the excretion rate of Dichlorobenzyl alcohol which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Phosphocreatine
Ertugliflozin may increase the excretion rate of Phosphocreatine which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Oxabolone cipionate
Ertugliflozin may increase the excretion rate of Oxabolone cipionate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Inositol
Ertugliflozin may increase the excretion rate of Inositol which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Alclofenac
Ertugliflozin may increase the excretion rate of Alclofenac which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Inosine pranobex
Ertugliflozin may increase the excretion rate of Inosine pranobex which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Nedaplatin
Ertugliflozin may increase the excretion rate of Nedaplatin which could result in a lower serum level and potentially a reduction in efficacy.